Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
BMJ 2008;336:232-233 (2 February), doi:10.1136/bmj.39471.690440.3A
| The first 100% of the full text of this article appears below. |
I found Wilt and NDows article on diagnosing benign prostatic hyperplasia unhelpful from the point of view of a general prctitioner seeing a man presenting with lower urinary tract symptoms, who is worried about cancer.1 I dont see how it would reassure him to know that he is no more likely to have cancer than someone without these symptoms. The point is that he has got symptoms and wants an explanation. How do I know he hasnt got an invasive carcinoma?
Surely digital rectal examination (DRE) and prostate specific antigen (PSA) have a part to play here. The American Urological Association guidelines, which are cited in the next paragraph, specifically advise DRE and PSA in the routine workup of these patients.2 The use of PSA in asymptomatic men, as a population screening tool, is a different issue.
Jeremy L Menage, general practitioner
1 Nuneaton CV10 0PB
jeremy.menage@nhs.net
Read all Rapid Responses